ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      57,795.40
      2.03%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      01/06/20212:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      12/21/20208:00AMGlobeNewswire Inc.Esperion to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      12/16/20207:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      12/16/20203:00AMGlobeNewswire Inc.First-in-class cholesterol-lowering treatment NILEMDO® * (bempedoic acid) tablet and its combination with ezetimibe NUSTENDI...NASDAQ:ESPREsperion Therapeutics Inc
      12/15/20207:49AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ESPREsperion Therapeutics Inc
      12/15/20207:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      12/15/20207:00AMGlobeNewswire Inc.ESPERION Appoints Sheldon Koenig as Chief Operating OfficerNASDAQ:ESPREsperion Therapeutics Inc
      12/03/20202:37PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
      11/16/20205:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      11/13/20209:14AMGlobeNewswire Inc.NEXLETOL® (bempedoic acid) Tablets Highlighted at AHA 2020 with Presentations of Analyses Demonstrating Significant Low-Dens...NASDAQ:ESPREsperion Therapeutics Inc
      11/12/20207:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      11/12/20206:17AMGlobeNewswire Inc.Esperion Announces Pricing of Offering of $250.0 Million of Convertible Senior Subordinated NotesNASDAQ:ESPREsperion Therapeutics Inc
      11/10/20204:30PMGlobeNewswire Inc.Esperion Announces Private Offering of $200.0 Million of Convertible Senior Subordinated NotesNASDAQ:ESPREsperion Therapeutics Inc
      11/06/20205:00PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      11/04/20204:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/02/20204:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      11/02/20204:01PMGlobeNewswire Inc.ESPERION Reports Third Quarter 2020 Financial Results and Provides Company UpdateNASDAQ:ESPREsperion Therapeutics Inc
      10/27/20208:00AMGlobeNewswire Inc.Esperion to Participate in Three Upcoming Virtual Investor ConferencesNASDAQ:ESPREsperion Therapeutics Inc
      10/19/20208:00AMGlobeNewswire Inc.Esperion to Report Third Quarter 2020 Financial Results November 2, 2020NASDAQ:ESPREsperion Therapeutics Inc
      10/07/20208:00AMGlobeNewswire Inc.NEXLETOL® (bempedoic acid) Tablets Highlighted in EAS 2020 Presentation of Analysis Demonstrating Significant Cholesterol Lo...NASDAQ:ESPREsperion Therapeutics Inc
      09/28/20204:06PMGlobeNewswire Inc.Esperion Launches U.S. Direct-to-Consumer Campaign to Accelerate Awareness of NEXLETOL® (bempedoic acid) Tablets and Increa...NASDAQ:ESPREsperion Therapeutics Inc
      09/02/20208:41AMGlobeNewswire Inc.Esperion to Participate in Two Upcoming Virtual Investor ConferencesNASDAQ:ESPREsperion Therapeutics Inc
      08/26/20209:07AMGlobeNewswire Inc.Esperion Announces Two Data Presentations of NEXLETOL® (bempedoic acid) Tablet at the ESC Congress 2020NASDAQ:ESPREsperion Therapeutics Inc
      08/21/20204:05PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      08/10/20205:19PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ESPREsperion Therapeutics Inc
      08/10/20205:18PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
      08/10/20204:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      08/10/20204:04PMGlobeNewswire Inc.Esperion Reports Second Quarter 2020 Financial Results and Provides Company UpdateNASDAQ:ESPREsperion Therapeutics Inc
      08/03/20207:26AMGlobeNewswire Inc.Esperion to Report Second Quarter 2020 Financial Results August 10, 2020NASDAQ:ESPREsperion Therapeutics Inc
      07/01/202011:12AMGlobeNewswire Inc.Esperion Announces Publication in the Journal of the American Medical Association Cardiology of Pooled Efficacy Analysis from...NASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR